References
- Yokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328: 184–94.
- Gabius H-J. Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 2000; 87: 108–21.
- Danguy A. Perspectives in modern glycohistochem-istry. Eur J Histochem 1995; 39: 5–14.
- Gabius H-J. Animal lectins. Eur J Biochem 1997; 243: 543 — 76.
- André S, Kojima S, Yamazaki N, et al. Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol 1999; 125: 461–74.
- Kaltner H, Stierstorfer B. Animal lectins as cell adhe-sion molecules. Acta Anat 1998; 161: 162–79.
- Gabius H-J. Glycohistochemistry: the why and how of detection and localization of endogenous lectins. Anat Histol Embryol 2001; 30: 3–31.
- Plzak J, Smetana Jr K, Betka J, Kodet R, Kaltner H, Gabius H-J. Endogenous lectins as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and lar-ynx. Int J Mol Med 2000; 5: 369–72.
- Plzak J, Smetana Jr K, Hrdli6kova. E, et al. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as marker of differentiation. Int J Oncol 2001; 19: 59–64.
- Watt FM. Stem cell patterning in mammalian epider-mis. Curr Opin Genet Dev 2001; 11: 410–7.
- Choufani G, Nagy N, Saussez S, et al. The levels of expression of galectin-1, galectin-3 and Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck can-cers. Cancer 1999; 86: 2353–63.
- Delorge S, Saussez S, Pelc P, et al. Correlation of galectin-3/galectin-3-binding sites with the differentia-tion status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 2000; 122: 834–41.